Progyny GAAP EPS of $0.18 beats by $0.11, revenue of $258.4M beats by $11.77M

• Progyny press release (NASDAQ:PGNY): Q1 GAAP EPS of $0.18 beats by $0.11.
• Revenue of $258.4M (+50.1% Y/Y) beats by $11.77M.

• The Company is providing the following financial guidance for the full year ending December 31, 2023 and the three-month period ending June 30, 2023:

  • Full Year 2023 Outlook:
    • Revenue is now projected to be $1,040 million to $1,065 million vs $1.02B consensus, reflecting growth of 32% to 35%
    • Net income is projected to be $43.6 million to $49.0 million, or $0.42 to $0.48 per diluted share vs $0.29 consensus, on the basis of approximately 103 million assumed weighted-average fully diluted-shares outstanding
    • Adjusted EBITDA¹ is projected to be $176.5 million to $184.0 million
  • Second Quarter of 2023 Outlook:
    • Revenue is projected to be $260.0 million to $265.0 million vs $253.58M consensus, reflecting growth of 33% to 36%
    • Net income is projected to be $9.3 million to $10.4 million, or $0.09 to $0.10 per diluted share vs $0.08 consensus, on the basis of approximately 102 million assumed weighted-average fully diluted-shares outstanding
    • Adjusted EBITDA¹ is projected to be $44.0 million to $45.5 million

Comments

[vetri-india]

A blind BUY & HOLD for the next 3 yrs atleast. $PGNY

[lbeachmike]

Anybody else own this?

[Senopta]

@lbeachmike yes

[JeffSizemore]

@lbeachmike would be nice if management stopped selling shares